Larimar Therapeutics Inc. buy Quitte
Start price
04.10.16
/
50%
€37.88
Target price
31.01.17
€44.38
Performance (%)
17.14%
End price
31.01.17
€44.38
Summary
This prediction ended on 31.01.17 with a price of €44.38. The BUY prediction by Quitte finished with a performance of 17.14%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Larimar Therapeutics Inc. | 4.082% | 4.082% | 133.143% | 4.082% |
| iShares Core DAX® | 4,85 % | -4,42 % | 13,10 % | 46,14 % |
| iShares Nasdaq 100 | 4,00 % | -3,28 % | 31,34 % | 76,07 % |
| iShares Nikkei 225® | 4,22 % | -6,22 % | 44,47 % | 47,14 % |
| iShares S&P 500 | 3,32 % | -3,17 % | 24,36 % | 57,68 % |
Comments by Quitte for this prediction
In the thread Zafgen Inc. diskutieren